GPD2 and neoplasm: Previous studies have demonstrated that mGPDH acts as a mitochondrial oxidative modulator and is usually expressed in low amounts in several cancers25, 26; however, the effect of decreased mGPDH expression in tumour progression has remained largely unknown.